LMDX News and Press, LumiraDx Limited From 10/23/23

2023-10-23 13:18:40 ET Gainers: LumiraDx Limited ( LMDX ) +186% . Akumin ( AKU ) +178% . Textainer Group Holdings Limited ( TGH ) +44% . Cel-Sci Corp. ( CVM ) +41% . ImmunoPrecise Antibodies Ltd ( IPA ) +27% . Soluna Holdings...

2023-10-23 12:19:40 ET DENVER, Colo., Oct. 23, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; LumiraDx Ltd (NASDAQ: LMDX), CEL-SCI Corp (AMEX: CVM), Inpixon (NASDAQ: INPX), INVO Bioscience Inc (NA...

2023-10-23 10:05:13 ET DENVER, Colo., Oct. 23, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; LumiraDx Ltd (NASDAQ: LMDX), Inpixon (NASDAQ: INPX), INVO Bioscience Inc (NASDAQ: INVO), Tempest Therapeutics...

2023-10-23 08:06:40 ET DENVER, Colo., Oct 23, 2023 ( www.247marketnews.com )- LumiraDx Limited (NASDAQ: LMDX) announced, after Friday’s market close, that it formed a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-...

2023-10-23 07:29:44 ET More on LumiraDx LumiraDx Limited (LMDX) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on LumiraDx Historical earnings data for LumiraDx Financial information for LumiraDx For further details see: Lumi...

Made possible thanks to unrestricted grant funding from AstraZeneca and run by the official charity of Everton Football Club – Everton in the Community – the Liverpool-based hub will provide significant support for individuals suffering from chronic breathlessness and other heart an...

2023-08-24 13:34:04 ET LumiraDx Limited (LMDX) Q2 2023 Earnings Call Transcript August 24, 2023 08:30 AM ET Company Participants Melissa Garcia - Vice President Corporate Counsel Ron Zwanziger - Chairman & Chief Executive Officer Dorian LeBlanc - Chief Financ...

2023-08-24 08:18:08 ET More on LumiraDx LumiraDx gains on FDA submission for COVID Ultra Test LumiraDx jumps 34% on U.K. approval for COVID and RSV tests LumiraDx wins U.S., U.K. nod for COVID/flu assay LumiraDx gets $14.2M in grants from Gates Foundation to ...

LONDON, Aug. 24, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ: LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its second quarter ended June 30, 2023. Second quarter 2023 revenues of $21.0 million Submitted First 510(k) Appl...

LONDON, Aug. 16, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited  (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its second quarter financial results on Thursday, August 24, 2023. On the day of the release, LumiraDx will host a confer...